These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
591 related items for PubMed ID: 15378790
21. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach. Flucke U, Steinborn E, Dries V, Mönig SP, Schneider PM, Thiele J, Hölscher AH, Dienes HP, Baldus SE. Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727 [Abstract] [Full Text] [Related]
22. Prognostic significance of mucin expression in gastric carcinoma. Kocer B, Soran A, Kiyak G, Erdogan S, Eroglu A, Bozkurt B, Solak C, Cengiz O. Dig Dis Sci; 2004 Jun; 49(6):954-64. PubMed ID: 15309883 [Abstract] [Full Text] [Related]
23. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors. Xu Y, Kimura N, Yoshida R, Lin H, Yoshinaga K. Oncol Rep; 2001 Jun; 8(5):1177-82. PubMed ID: 11496338 [Abstract] [Full Text] [Related]
24. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. Cancer; 2001 Sep 15; 92(6):1427-34. PubMed ID: 11745219 [Abstract] [Full Text] [Related]
25. MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Pinto-de-Sousa J, Reis CA, David L, Pimenta A, Cardoso-de-Oliveira M. Virchows Arch; 2004 Mar 15; 444(3):224-30. PubMed ID: 14758553 [Abstract] [Full Text] [Related]
26. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E. Clin Cancer Res; 1998 Nov 15; 4(11):2605-14. PubMed ID: 9829723 [Abstract] [Full Text] [Related]
29. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M, de Bolos C, Cardesa A. Am J Surg Pathol; 2005 Jun 15; 29(6):806-13. PubMed ID: 15897748 [Abstract] [Full Text] [Related]
30. MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, Makuuchi H. Oncol Rep; 2001 Jun 15; 8(3):485-9. PubMed ID: 11295067 [Abstract] [Full Text] [Related]
32. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Gürbüz Y, Kahlke V, Klöppel G. Virchows Arch; 2002 May 15; 440(5):505-11. PubMed ID: 12021925 [Abstract] [Full Text] [Related]
35. Mucin expression profile is related to biological and clinical characteristics of intraductal papillary-mucinous tumors of the pancreas. Ito H, Endo T, Oka T, Matumoto T, Abe T, Toyota M, Imai K, Satoh M, Maguchi H, Shinohara T. Pancreas; 2005 May 15; 30(4):e96-102. PubMed ID: 15841035 [Abstract] [Full Text] [Related]
38. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. Yonezawa S, Nakamura A, Horinouchi M, Sato E. J Hepatobiliary Pancreat Surg; 2002 May 15; 9(3):328-41. PubMed ID: 12353144 [Abstract] [Full Text] [Related]
39. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Chu PG, Schwarz RE, Lau SK, Yen Y, Weiss LM. Am J Surg Pathol; 2005 Mar 15; 29(3):359-67. PubMed ID: 15725805 [Abstract] [Full Text] [Related]